Skip to content

NUGENEREX IMMUNO-ONCOLOGY, INC.

company.status.inactive

CIK 1804585fmd_1739YSZ6KVBGJ8B1BDNPV8AYHYManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Aug 01, 2018 to Apr 30, 2021, 11 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading